David BA - Theralase Technologies President Division
| TLT Stock | CAD 0.26 0.01 3.70% |
President
David BA is President Division of Theralase Technologies
| Address | 41 Hollinger Road, Toronto, ON, Canada, M4B 3G4 |
| Phone | 416 699 5273 |
| Web | https://www.theralase.com |
Theralase Technologies Management Efficiency
The company has return on total asset (ROA) of (0.8188) % which means that it has lost $0.8188 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (2.3855) %, meaning that it generated substantial loss on money invested by shareholders. Theralase Technologies' management efficiency ratios could be used to measure how well Theralase Technologies manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -1.46 in 2024. Return On Capital Employed is likely to drop to -2.19 in 2024. At this time, Theralase Technologies' Total Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to climb to about 966 K in 2024, whereas Total Current Assets are likely to drop slightly above 1.4 M in 2024.Similar Executives
| Found 7 records | PRESIDENT Age | ||
| James DeMare | Bank of America | 54 | |
| Jeneen Marziani | Bank of America | N/A | |
| Aron Levine | Bank of America | N/A | |
| Paul Douglas | Toronto Dominion Bank | 67 | |
| Dean Athanasia | Bank of America | 57 | |
| Matthew Koder | Bank of America | 52 | |
| Daniel Pinto | JPMorgan Chase Co | 61 | |
Management Performance
| Return On Equity | -2.39 | ||||
| Return On Asset | -0.82 |
Theralase Technologies Leadership Team
Elected by the shareholders, the Theralase Technologies' board of directors comprises two types of representatives: Theralase Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Theralase. The board's role is to monitor Theralase Technologies' management team and ensure that shareholders' interests are well served. Theralase Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Theralase Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Lori Leach, Marketing Consultant | ||
| Terry DVM, Equine Consultant | ||
| Roger DumoulinWhite, President CEO, Director | ||
| David BA, President Division | ||
| DSc MD, Chief CEO | ||
| Vaughn Wyant, Marketing Consultant | ||
| Kristina CPA, CFO Director |
Theralase Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Theralase Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -2.39 | ||||
| Return On Asset | -0.82 | ||||
| Operating Margin | (11.30) % | ||||
| Current Valuation | 65.65 M | ||||
| Shares Outstanding | 245.54 M | ||||
| Shares Owned By Insiders | 8.70 % | ||||
| Number Of Shares Shorted | 42.79 K | ||||
| Price To Earning | (9.79) X | ||||
| Price To Book | 29.54 X | ||||
| Price To Sales | 71.32 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Theralase Stock Analysis
When running Theralase Technologies' price analysis, check to measure Theralase Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theralase Technologies is operating at the current time. Most of Theralase Technologies' value examination focuses on studying past and present price action to predict the probability of Theralase Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theralase Technologies' price. Additionally, you may evaluate how the addition of Theralase Technologies to your portfolios can decrease your overall portfolio volatility.